Home LiteratureArticle Details
PMID: 29528531 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia.

European journal of neurology ·Vol. 25 ·No. 7 ·2018-00-00 ·Pages 943-e71

Rydning SL, Dudesek A, Rimmele F, Funke C, Krüger S, Biskup S, Vigeland MD, Hjorthaug HS, Sejersted Y, Tallaksen C, Selmer KK, Kamm C

Abstract

Hereditary spastic paraplegias (HSPs) are clinically and genetically heterogeneous monogenic disorders. To date, nearly 70 genes are known to be causative. The aim of this project was to identify the genetic cause of autosomal dominantly inherited pure HSP in two large, unrelated non-consanguineous families. The two families were characterized clinically and selected members underwent whole exome sequencing. Potentially disease-causing variants were confirmed by Sanger sequencing and their functional consequences on protein function were predicted by bioinformatic prediction tools. The patients presented with pure spastic paraplegia with age of onset between 9 and 46 years. In both families, a novel heterozygous missense variant in ERLIN2, c.386G>C; p.Ser129Thr, was the only potentially pathogenic variant identified that segregated with the disease. Biallelic variants in ERLIN2 are known to cause recessive HSP type SPG18. Here, the first two families with an autosomal dominant, pure form of HSP caused by a novel ERLIN2 heterozygous missense variant are described. These findings expand the mutational and inheritance spectrum of SPG18. ERLIN2 variants should also be considered in the diagnostic evaluation of patients with autosomal dominant HSP.

Keywords
ERLIN2 ERAD SPG18 autosomal dominant hereditary spastic paraplegia neurodegeneration next generation sequencing
MeSH Terms
Adult Female Heterozygote Humans Male Membrane Proteins/genetics Middle Aged Mutation Pedigree Spastic Paraplegia, Hereditary/genetics
Chemicals
ERLIN2 protein, human Membrane Proteins
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Rydning S L
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. | Department of Neurology, Oslo University Hospital, Oslo, Norway.
Dudesek A
Department of Neurology, University of Rostock, Rostock, Germany. | German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany, Germany.
Rimmele F
Department of Neurology, University of Rostock, Rostock, Germany. | German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany, Germany.
Funke C
CeGaT GmbH, Center for Genomics and Transcriptomics, Tübingen, Germany.
Krüger S
CeGaT GmbH, Center for Genomics and Transcriptomics, Tübingen, Germany.
Biskup S
CeGaT GmbH, Center for Genomics and Transcriptomics, Tübingen, Germany. | Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.
Vigeland M D
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Hjorthaug H S
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Sejersted Y
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Tallaksen C
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. | Department of Neurology, Oslo University Hospital, Oslo, Norway.
Selmer K K
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. | Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Kamm C ORCID
Department of Neurology, University of Rostock, Rostock, Germany.
Article Info
Journal
European journal of neurology
Abbr.
Eur J Neurol
ISSN
1468-1331
Published
2018-00-00
Epub
2018-00-15
Pages
943-e71
Language
English
Region
England
NLM ID
9506311
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]